MLTXNASDAQHealthcare · Biotechnology

MoonLake Immunotherapeutics

$17.05+4.15%(+$0.68)

TickerSpark Score

44/100

Weak

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MLTX research report →

52-Week Range20% of range

Low $5.95

Current $17.05

High $62.75

Companywww.moonlaketx.com

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis.

CEO: Jorge Santos da Silva
IPO: 2020
Employees: 100
HQ: Zug, CH

Price Chart

-57.67% · this period

Valuation

Market Cap: $1.26B
P/E: -4.73
P/S: 0.00
P/B: 4.78
EV/EBITDA: -4.25
Div Yield: 0.00%

Profitability

Gross Margin: 0.00%
Op Margin: 0.00%
Net Margin: 0.00%
ROE: -85.61%
ROIC: -75.28%

Growth & Income

Revenue: $0 · 0.00%
Net Income: $-227,318,000 · -91.13%
EPS: $-3.53 · -86.77%
Op Income: $-244,834,000
FCF YoY: -67.40%

Performance & Tape

52W High: $62.75
52W Low: $5.95
50D MA: $17.41
200D MA: $22.59
Beta: 1.01
Avg Volume: 1.16M

Get TickerSpark's AI analysis on MLTX

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

Date	Insider	Role	Type	Shares	Value
May 11, 26	Bodenstedt Matthias	officer: Chief Financial Officer	sell	13,653	$273.33K
Apr 14, 26	Bodenstedt Matthias	officer: Chief Financial Officer	sell	2,426	$47.45K
Apr 10, 26	Santos da Silva Jorge	director, officer: Chief Executive Officer	sell	98,127	$1.81M
Apr 13, 26	Santos da Silva Jorge	director, officer: Chief Executive Officer	sell	51,873	$945.64K
Apr 9, 26	Bodenstedt Matthias	officer: Chief Financial Officer	sell	85,870	$1.63M
Apr 10, 26	Bodenstedt Matthias	officer: Chief Financial Officer	sell	1,925	$37.56K
Mar 31, 26	BVF PARTNERS L P/IL	director, 10 percent owner:	sell	1,932,354	$32.44M
Mar 31, 26	BVF PARTNERS L P/IL	director, 10 percent owner:	sell	1,569,116	$26.35M
Mar 31, 26	BVF PARTNERS L P/IL	director, 10 percent owner:	sell	248,530	$4.17M
Jan 7, 26	Bodenstedt Matthias	officer: Chief Financial Officer	other	354,296	$0